PO-40 PRODIGE: a randomized placebo-controlled trial of long-term thromboprophylaxis using dalteparin low molecular weight heparin (LMWH) in patients with newly diagnosed malignant glioma: updated results Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Perry, J
  • Rogers, L
  • Laperriere, N
  • Julian, James
  • Geerts, W
  • Agnelli, G
  • Malkin, M
  • Sawaya, R
  • Baker, R
  • Finch, T
  • Levine, M

publication date

  • January 2007